|
Bruce Alberts
Dan
Burkhardt
France A. Córdova
William
H. Danforth
Brady J.
Deaton
Hugh Grant
Richard
Herman
David W.
Kemper
Alex F.
McCalla
John
F. McDonnell
Philip
Needleman
Peter H.
Raven
Alfonso
Romo Garza
P. Roy
Vagelos
Robert L.
Virgil
Mark S.
Wrighton
Usha
Barwale Zehr
|
Board of Trustees
Philip Needleman, Ph.D.
Scientific Partner
Prospect Venture Parnters
Philip Needleman currently is
Scientific Partner with Prospect
Venture Parnters (San Francisco)
and served as Associate Dean for
Special Projects at Washtington
University Medical School (St
Louis) in 2004. He is the former
Chief Scientific Officer and
Senior Executive Vice President
of Pharmacia Corporation who
retired following the Pfizer
acquisition.. In April 2000,
following the merger of Monsanto
and Pharmacia, he became
Chairman, Research and
Development of Pharmacia. He
joined Monsanto in 1989 as Chief
Scientist and became President
of Searle Pharmaceutical Company
(1993). He received his B.Sc.
(Pharmacy, 1960) and M.Sc.
(Pharmacology, 1962) from the
Philadelphia College of Pharmacy
and Science; received his Ph.D.
(Pharmacology, 1964) from U.
Maryland Medical School; and was
a postdoctoral fellow at
Washington University Medical
School. He joined the faculty
(1967) and rose to Chairman of
the Department of Pharmacology
(1976 to 1989). During that
time, he was selected Basic
Science Teacher of the Year five
times. He was elected a member
of the National Academy of
Sciences (NAS,1987) and the
Institute of Medicine (1993). At
the NAS he chaired the
Pharmacology-Physiology section
(2001-2004) and was elected
(2004) to the NAS Council (board
of trustees). . He is a member
of the Washington University
Board of Trustees. In St Louis
he is a member of the boards of
the St Louis Science Center, the
Barnes Jewish Hospital Board,
and the Plant and Life Sciences
Coalition. In 2005 he received
the NYU Applied Biotechnology
Award and the National Academy
of Science Award for the
Industrial Application of
Research.
In 2002, he was appointed
Special Advisor to the President
for Research and Development at
Ben-Gurion University of the
Negev, and has joined the
University's Advisory committee
for the creation of a National
Institute for Biotechnology in
the Negev
Needleman has garnered numerous
honors, including the: John
Jacob Abel Award of the American
Pharmacology Society (1974);
Research Achievement Award from
the American Heart Association
(1988); Washington University's
Distinguished Faculty Award
(1987), Second Century Award
from the medical school (1994),
and honorary doctorate degree
(1999); C. Chester Stock Award
Lectureship at Memorial-Sloan
Kettering Cancer Center (2001);
the Industrial Research
Institute Medal (2001); the Amercian Society of Experimental
Therapeutics award; and in 2005
the NAS Award for the Industrial
Application of Science.
|